WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Clinical trials for WARM AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new WARM AUTOIMMUNE HEMOLYTIC ANEMIA trials appear
Sign up with your email to follow new studies for WARM AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lifeline for anemia patients: drug access extended for those who responded
Disease control TEMPORARILY_NOT_AVAILABLEThis program offers continued treatment with nipocalimab to people with warm autoimmune hemolytic anemia (wAIHA) who saw improvement in a previous study. Participants must have completed the earlier 28-week study and still be benefiting from the drug. The goal is to keep their co…
Matched conditions: WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 06, 2026 16:13 UTC
-
New hope for rare blood disorder: drug targets red blood cell destruction
Disease control OngoingThis study tests a drug called M281 in adults with warm autoimmune hemolytic anemia, a condition where the immune system attacks red blood cells. The goal is to see if M281 can safely improve hemoglobin levels and reduce fatigue. About 118 participants will receive either M281 or…
Matched conditions: WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE2, PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC